Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
| US |
|
Fubotv Inc
NYSE:FUBO
|
Media
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
| US |
|
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
| CN |
|
NIO Inc
NYSE:NIO
|
Automobiles
|
| US |
|
Fluor Corp
NYSE:FLR
|
Construction
|
| US |
|
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
| US |
|
TopBuild Corp
NYSE:BLD
|
Consumer products
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
Health Care
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
| US |
|
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
| US |
|
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
| US |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
| US |
|
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
| US |
|
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
222.34
324.5
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
|
|
Fubotv Inc
NYSE:FUBO
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
C
|
C3.ai Inc
NYSE:AI
|
US |
|
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
|
NIO Inc
NYSE:NIO
|
CN |
|
|
Fluor Corp
NYSE:FLR
|
US |
|
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
|
TopBuild Corp
NYSE:BLD
|
US |
|
|
Abbott Laboratories
NYSE:ABT
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
|
|
Occidental Petroleum Corp
NYSE:OXY
|
US |
|
|
Matrix Service Co
NASDAQ:MTRX
|
US |
|
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
|
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Shenzhen Mindray Bio-Medical Electronics Co Ltd
Shenzhen Mindray Bio-Medical Electronics Co Ltd
Accrued Liabilities
Shenzhen Mindray Bio-Medical Electronics Co Ltd
Accrued Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
Accrued Liabilities
¥3.9B
|
CAGR 3-Years
15%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
|
A
|
APT Medical Inc
SSE:688617
|
Accrued Liabilities
¥132.8m
|
CAGR 3-Years
41%
|
CAGR 5-Years
42%
|
CAGR 10-Years
N/A
|
|
|
J
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
|
Accrued Liabilities
¥321.1m
|
CAGR 3-Years
38%
|
CAGR 5-Years
42%
|
CAGR 10-Years
49%
|
|
|
J
|
Jafron Biomedical Co Ltd
SZSE:300529
|
Accrued Liabilities
¥116.9m
|
CAGR 3-Years
14%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
|
L
|
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
|
Accrued Liabilities
¥133.1m
|
CAGR 3-Years
26%
|
CAGR 5-Years
3%
|
CAGR 10-Years
26%
|
|
|
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
|
Accrued Liabilities
¥879.6m
|
CAGR 3-Years
14%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
Glance View
Shenzhen Mindray Bio-Medical Electronics Co., Ltd., founded in 1991, has evolved into a leading global player in the medical device industry, with a compelling story of innovation and resilience at its core. Originating from the bustling tech hub of Shenzhen, the company specializes in developing and manufacturing high-quality medical equipment and solutions, particularly in the fields of imaging, in-vitro diagnostics, and patient monitoring. Mindray's commitment to advanced research and development has led it to achieve a strong competitive edge, enabling it to penetrate international markets and establish partnerships with healthcare providers across over 190 countries. With an unwavering focus on improving healthcare outcomes, Mindray is positioned not just as a manufacturer, but as a trusted partner in enhancing patient care worldwide. As an investor, you would be interested to know that Mindray's growth trajectory has been remarkable, characterized by steady revenue increases and robust profitability. The company's diversified product portfolio, including vital sign monitors, ultrasound systems, and laboratory solutions, addresses a wide array of healthcare needs, making it resilient to market fluctuations. Moreover, in response to the growing global emphasis on healthcare quality, Mindray continuously expands its innovations, investing significantly in R&D and leveraging advanced technologies like artificial intelligence. With a strong balance sheet and a commitment to ethical business practices, Mindray not only seeks to drive strong financial performance but also aims to foster a sustainable impact on global health, making it an attractive prospect for forward-thinking investors aiming to align their portfolios with socially responsible investments.
See Also
What is Shenzhen Mindray Bio-Medical Electronics Co Ltd's Accrued Liabilities?
Accrued Liabilities
3.9B
CNY
Based on the financial report for Jun 30, 2024, Shenzhen Mindray Bio-Medical Electronics Co Ltd's Accrued Liabilities amounts to 3.9B CNY.
What is Shenzhen Mindray Bio-Medical Electronics Co Ltd's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 5Y
25%
Over the last year, the Accrued Liabilities growth was 37%. The average annual Accrued Liabilities growth rates for Shenzhen Mindray Bio-Medical Electronics Co Ltd have been 15% over the past three years , 25% over the past five years .
You don't have any saved screeners yet
